PACIRA PHARMACEUTICALS INC's ticker is PCRX and the CUSIP is 695127100. A total of 262 filers reported holding PACIRA PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is 0.51 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $767 | -3.8% | 27,515 | 0.0% | 0.00% | 0.0% |
Q1 2024 | $797 | -13.2% | 27,515 | 0.0% | 0.00% | -50.0% |
Q4 2023 | $918 | +8.6% | 27,515 | 0.0% | 0.00% | 0.0% |
Q3 2023 | $845 | -22.3% | 27,515 | 0.0% | 0.00% | 0.0% |
Q2 2023 | $1,087 | -0.6% | 27,515 | 0.0% | 0.00% | -33.3% |
Q1 2023 | $1,094 | +2.9% | 27,515 | 0.0% | 0.00% | 0.0% |
Q4 2022 | $1,063 | -99.9% | 27,515 | 0.0% | 0.00% | -25.0% |
Q3 2022 | $1,482,000 | -7.1% | 27,515 | 0.0% | 0.00% | -20.0% |
Q2 2022 | $1,596,000 | -23.3% | 27,515 | 0.0% | 0.01% | 0.0% |
Q1 2022 | $2,082,000 | +34.6% | 27,515 | +10.0% | 0.01% | +25.0% |
Q4 2021 | $1,547,000 | +12.5% | 25,015 | +2.9% | 0.00% | 0.0% |
Q3 2021 | $1,375,000 | -6.5% | 24,315 | 0.0% | 0.00% | 0.0% |
Q2 2021 | $1,471,000 | -14.2% | 24,315 | 0.0% | 0.00% | -33.3% |
Q1 2021 | $1,714,000 | +19.9% | 24,315 | 0.0% | 0.01% | +20.0% |
Q4 2020 | $1,430,000 | -33.2% | 24,315 | -33.4% | 0.01% | -50.0% |
Q3 2020 | $2,141,000 | +109.7% | 36,515 | +43.1% | 0.01% | +66.7% |
Q3 2019 | $1,021,000 | -55.9% | 25,515 | -51.5% | 0.01% | -50.0% |
Q2 2019 | $2,313,000 | +145.3% | 52,630 | +156.1% | 0.01% | +100.0% |
Q1 2019 | $943,000 | +26.7% | 20,548 | +14.8% | 0.01% | +20.0% |
Q4 2018 | $744,000 | -21.1% | 17,893 | -12.9% | 0.01% | -16.7% |
Q3 2018 | $943,000 | +58.5% | 20,548 | +7.3% | 0.01% | +50.0% |
Q2 2018 | $595,000 | +6.1% | 19,155 | +5.7% | 0.00% | 0.0% |
Q1 2018 | $561,000 | -18.5% | 18,115 | -2.2% | 0.00% | -20.0% |
Q4 2017 | $688,000 | 0.0% | 18,515 | 0.0% | 0.01% | 0.0% |
Q3 2017 | $688,000 | -22.9% | 18,515 | 0.0% | 0.01% | -28.6% |
Q2 2017 | $892,000 | +5.1% | 18,515 | 0.0% | 0.01% | -12.5% |
Q1 2017 | $849,000 | +37.4% | 18,515 | -7.5% | 0.01% | +14.3% |
Q4 2016 | $618,000 | -1.9% | 20,015 | +8.1% | 0.01% | 0.0% |
Q3 2016 | $630,000 | -10.5% | 18,515 | 0.0% | 0.01% | -12.5% |
Q2 2016 | $704,000 | -24.3% | 18,515 | +1.3% | 0.01% | -27.3% |
Q1 2016 | $930,000 | -35.2% | 18,280 | -1.9% | 0.01% | -31.2% |
Q4 2015 | $1,435,000 | +90.6% | 18,630 | +1.6% | 0.02% | +77.8% |
Q3 2015 | $753,000 | -39.6% | 18,330 | +4.0% | 0.01% | -40.0% |
Q2 2015 | $1,247,000 | -17.4% | 17,630 | +3.8% | 0.02% | -21.1% |
Q1 2015 | $1,509,000 | -13.6% | 16,980 | -11.8% | 0.02% | -13.6% |
Q4 2014 | $1,747,000 | -14.2% | 19,250 | -8.3% | 0.02% | -21.4% |
Q3 2014 | $2,035,000 | +8.3% | 21,000 | +2.7% | 0.03% | 0.0% |
Q2 2014 | $1,879,000 | +34.2% | 20,450 | +2.2% | 0.03% | +27.3% |
Q1 2014 | $1,400,000 | +30.5% | 20,000 | +5.3% | 0.02% | +22.2% |
Q4 2013 | $1,073,000 | +20.6% | 19,000 | +2.7% | 0.02% | +12.5% |
Q3 2013 | $890,000 | +80.5% | 18,500 | +6.9% | 0.02% | +60.0% |
Q2 2013 | $493,000 | – | 17,300 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Tamarack Advisers, LP | 273,000 | $8,818,000 | 6.24% |
Standard Investments LLC | 775,388 | $25,045,000 | 4.58% |
ARMISTICE CAPITAL, LLC | 400,000 | $12,920,000 | 3.06% |
HealthCor Management, L.P. | 1,575,000 | $50,873,000 | 2.88% |
DARUMA CAPITAL MANAGEMENT LLC | 1,219,642 | $39,394,000 | 2.24% |
Consonance Capital Management LP | 631,805 | $20,407,000 | 2.24% |
Rock Springs Capital Management LP | 713,000 | $23,030,000 | 1.54% |
Biondo Investment Advisors, LLC | 142,473 | $4,602,000 | 1.52% |
Opus Point Partners Management, LLC | 50,000 | $1,615,000 | 1.29% |
Partner Investment Management, L.P. | 26,690 | $862,000 | 1.14% |